4 completed, 1 recruiting, 1 unknown, 1 withdrawn. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Spinal Dysraphism: new trials by email Literature Review of Spinal Dysraphism trials Research Report on Spinal Dysraphism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC Vibegron - Neurogenic Detrusor Overactivity | Phase 2 / Phase 3 | Recruiting | Urovant Sciences GmbH | 71 | 2022-10-12 | 2026-06-15 |
| Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB Lactobacillus rhamnosus GG - Lower Urinary Tract Symptoms | Phase 2 | Completed | Medstar Health Research Institute | 96 | 2016-01-01 | 2020-05-12 |
| Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB Lactobacillus - Lower Urinary Tract Symptoms | Phase 2 | Completed | Medstar Health Research Institute | 7 | 2016-01-01 | 2020-04-24 |
| Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence Acetazolamide, prone positioning, Acetazolamide+ prone positioning - Fibrolipoma of Filum Terminale, Lipomyelomeningocele | Phase 2 | Unknown | Tehran University of Medical Sciences | 144 | 2012-10-01 | 2015-04-21 |
| Lumbar to Sacral Ventral Nerve Re-Routing lumbar to sacral ventral nerve re-routing procedure - Urinary Incontinence, Spinal Cord Injury | Phase 2 | Completed | Kenneth Peters, MD | 13 | 2006-09-01 | 2015-10-14 |
| Coping Skills Training (CST) for Children With Chronic Health Conditions Coping Skills Training - Rheumatologic Conditions (JRA,Lupus), Epilepsy | Phase 2 | Completed | Children's Hospital and Health System Foundation, Wisconsin | 38 | 2006-07-01 | 2012-02-20 |
| Probiotics in Girls With Spina Bifida Urex-cap-5 (2x10^9 cfu each of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1), Placebo - Urinary Tract Infection | Phase 2 | Withdrawn | Baylor College of Medicine | 2015-09-15 |
Spinal Cord Injuries (4) · Lower Urinary Tract Symptoms (2) · Asthma (1) · Bacteriuria (1) · Cerebrospinal Fluid Leak (1) · Epilepsy (1) · Lipomyelomeningocele (1) · Meningocele (1) · Meningomyelocele (1) · Myelitis, Transverse (1) · Neoplasms (1) · Neural Tube Defects (1) · Spina Bifida Occulta (1) · Urinary Incontinence (1)
Congenital Abnormalities (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Nervous System Diseases (7) · Nervous System Malformations (7) · Neural Tube Defects (6) · Central Nervous System Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Trauma, Nervous System (5) · Wounds and Injuries (5) · Signs and Symptoms (4) · Spinal Cord Diseases (4) · Urological Manifestations (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Immune System Diseases (2)
Acetazolamide (1) · Lacteol (1) · N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide (1) · Prone Position (1)
Medstar Health Research Institute (2) · Baylor College of Medicine (1) · Children's Hospital and Health System Foundation, Wisconsin (1) · Kenneth Peters, MD (1) · Tehran University of Medical Sciences (1) · Urovant Sciences GmbH (1)
United States (5) · Belgium (1) · Canada (1) · Croatia (1) · Denmark (1) · Georgia (1) · Iran (1) · Jordan (1) · Latvia (1) · Lithuania (1) · Malaysia (1) · Philippines (1) · Poland (1) · Romania (1) · Serbia (1)
Betsy Roth-Wojcicki, MS, CPNP (1) · Eric A. Jones, MD (1) · Farideh Nejat, MD (1) · Hans Pohl, MD (1) · Janet Owens-Grillo (1) · Kathleen Sawin, DNS, CPNP, (1) · Kenneth M Peters, M.D. (1) · Suzanne L Groah, MD, MSPH (1)